Larkin JMG, et al. 5-year survival outcomes of the CheckMate 067 phase 3 trial of nivolumab plus ipilimumab (NIVO+IPI) combination therapy in advanced melanoma. Abstract LBA68_PR. ESMO Congress 2019, 28 sept, Barcelona, Spanje.
Robot- versus open cystectomie bij blaaskanker: een ‘non inferiority’-studie
aug 2018 | Chirurgie, Uro-oncologie